E. coli mediated gene silencing of betacatenin

Details for Australian Patent Application No. 2009313930 (hide)

Owner Marina Biotech, Inc.

Inventors Fruehauf, Johannes Heinrich; Vaze, Moreswhar Bhanudas; Laroux, Floyd Stephen; Sexton, Jessica Ann; Bolduc, Gilles Remeo

Agent FB Rice

Pub. Number AU-A-2009313930

PCT Pub. Number WO2010/057009

Priority 61/114,610 14.11.08 US

Filing date 13 November 2009

Wipo publication date 20 May 2010

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/72 (2006.01) Mutation or genetic engineering - Expression systems using regulatory sequences derived from the lac-operon

C12R 1/19 (2006.01)

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/057009 Priority application(s): WO2010/057009

22 September 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Fruehauf, Johannes Heinrich; Vaze, Moreswhar Bhanudas; Laroux, Floyd Stephen and Sexton, Jessica Ann

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313937-Chitosan derivatives alone or in combination for the treatment of MDR microbial infections

2009313929-Asymmetric TDD in flexible use spectrum